YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation - Concepedia

Concepedia

Publication | Open Access

YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation

DOI Full Paper Access

63

Citations

27

References

2022

Year

Chen‐Song Huang, Ying‐Qin Zhu, Qiong‐Cong Xu, Siyun Chen, Yue Huang, Guangyin Zhao, Xuhao Ni, Bo Liu, Wei Zhao, Xiaoyu Yin

Clinical and Translational Medicine

Abstract

YTHDF2 exhibits tumour oncogenic and cisplatin-desensitising properties, which may offer insight into the development of novel combination therapeutic strategies for ICC.

References

	Year	Citations

Page 1